Last reviewed · How we verify
NCT06719466
Diet Intervention on Obesity Related Complication
NA trial testing low linoleic acid (LA) in Obese in 30 participants. Participants enrolled and being followed up; not accepting new ones.
1 December 2024
Quick facts
| Lead sponsor | Zhang Manna |
|---|---|
| Phase | NA |
| Status | Active, enrolled |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | prevention |
| Enrollment | 30 |
| Start date | 1 September 2024 |
| Primary completion | 1 December 2024 |
| Estimated completion | 30 December 2024 |
| Sites | 1 location across China |
Drugs / interventions tested
- low linoleic acid (LA)
Conditions studied
- Obese — all drugs for Obese →
- Stomach Diseases — all drugs for Stomach Diseases →
Sponsor
Zhang Manna
Who can join
Adults 18 to 65, any sex, with Obese or Stomach Diseases. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Obesity has become a global epidemic, with more than 4 billion people expected to be overweight/obese by 2035, accounting for more than half of the world's population. Currently, there are sixteen recognized complications directly related to obesity, including gastroesophageal reflux disease. In recent years, people have increasingly paid attention to the damage caused by obesity to the stomach. In addition to gastroesophageal reflux disease, obesity also leads to various forms of gastric mucosal damage related diseases, such as gastric ulcers, chronic gastritis, intestinal metaplasia, and so on. This stuty aimed to observe the diet intervention on obesity related stomach.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06719466
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Obese
Currently open trials in the same condition.
- NCT07411560 — A Study Looking at How Weekly Injections of Two Hormones - GIP and Amylin - Affect Stomach-related Side Effects in Peopl · Phase 1 · recruiting
- NCT06590584 — Validity and Reliability of the 6-minute Pegboard Ring Test in Obese Individuals · recruiting
- NCT06562660 — The Effect of Mask Combined With High Flow Oxygen on Preoxygenation During Induction of General Anesthesia in Obese Pati · NA · recruiting
- NCT05819853 — Role of Semaglutide in Restoring Ovulation in Youth and Adults With Polycystic Ovary Syndrome · Phase 3 · recruiting
- NCT06448052 — Umbilical Cord Mesenchymal Stem Cell for Aging-related Low-grade Inflammation · Phase 1, PHASE2 · active not recruiting
Other Zhang Manna trials
Trials by the same sponsor.
- NCT05468476 — Multi-omics Analysis of Women With PCOS and Obesity Compared With Non-PCOS Obese Controls · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06719466 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Zhang Manna
- Last refreshed: 5 December 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06719466.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing